Related Experiment Video
Updated: Jun 5, 2025
Microscopic Replantation of Penile Glans Amputation Due to Circumcision
Published on: June 3, 2022
Biological welding: a rapid and bloodless approach to circumcision
Fanchun Zeng1,2,3, Quanfu Cao3,4, Fengwen Fu3
1Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Medical School, Shenzhen University, Shenzhen, 518060, China.
Background:
Circumcision is essential for male health, yet traditional methods are plagued by issues such as lengthy operative times, bleeding, and slow recovery. This study explores the application of biological welding technology in circumcision, assessing its potential as a safe and efficient novel surgical approach.
Methods:
In this study, 24 male adult dogs were randomly divided into two groups. The biological welding group underwent circumcision using biological welding technology, while the control group received traditional cut-and-suture circumcision. Clinical indicators such as surgical time, blood loss, pathological changes, and recovery time were observed and compared.
Results:
The biological welding group had a significantly shorter surgical time compared to the control group (2.33 ± 0.55 min vs. 27.06 ± 5.77 min, p < 0.001). The control group had an average blood loss of 22.35 ± 5.17 ml, whereas the biological welding group experienced zero blood loss (p < 0.001). Recovery time was also significantly shorter in the biological welding group (12.33 ± 3.50 d vs. 16.50 ± 2.57 d, p = 0.004), with a lower incidence of postoperative complications. Pathological analysis indicated that the thermal injury range in the biological welding group was controlled within 2 mm.
Conclusion:
Biological welding technology demonstrated advantages in circumcision, including short surgical time, no bleeding, minimal thermal damage, and rapid recovery, proving to be a safe and effective novel circumcision technique with potential clinical application value.
